Category: Vaccine
Preprint: Outcomes of SARS-CoV-2 reinfection
“Reinfection contributes additional risks of all-cause mortality, hospitalization, and adverse health outcomes in the pulmonary and several extrapulmonary organ systems.” More...
Germany: Fourth Covid vaccination offered for “a quieter and symptom-free summer”
Germany’s health minister Karl Lauterbach has announced plans to offer every citizen a fourth Covid vaccination so that they can have “a quieter and symptom-free summer”. More...
Denmark: Risk assessment for SARS-CoV-2 Omicron subvariants BA.5, BA.2.12.1 and BA.4
The sub-variants provisionally amount to 21% (BA.5) and 12.4% (BA.2.12.1) per June 8 2022. More...
France: BA.5 at 18% of sequences in week 22, 2022
Detection of BA.4 (1.1%) and BA.5 (18.0%) on the rise according to the week 21 Flash Survey in France. More...
WHO: Mass vaccination is not required nor recommended for Monkeypox
The World Health Organisation has updated their guidance on Monkeypox vaccinations today. More...
Monkeypox vaccine MVA repurposed for Covid-19
A new comparison study in PNAS from NIAID intramural scientists clearly shows that for SARS-CoV-2, nasal vaccination – particularly in two doses – has clear advantages over muscular delivery in laboratory mice. More...
UKHSA: Monkeypox Technical Briefing 1 published
The UK Health and Security Agency has published its first technical briefing for the Monkeypox outbreak in England. More...
Monkeypox: “We don’t know the efficacy of any of these monkeypox vaccines”
“How well MVA really protects humans from monkeypox is uncertain. More...
Israel: Fifth Covid-19 vaccination under consideration
A fifth round of Covid vaccinations is under consideration in Israel, according to the Jerusalem Post. More...
The peer reviewed child vaccine study that Twitter is trying to censor
We provide a link to a JAMA network peer-reviewed study that Twitter would prefer you didn’t read. More...